TFF Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on t…

Biotechnology
US, Austin [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
TFF Pharmaceuticals, Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
4,443,040
Volume
11,020,032
Volume on Avg.
1,698,354
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $0.07 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of TFFP's Analysis
CIK: 1733413 CUSIP: 87241J104 ISIN: US87241J2033 LEI: - UEI: -
Secondary Listings
TFFP has no secondary listings inside our databases.